Heidelberg Pharma AG (ETR:HPHA)
Germany
· Delayed Price · Currency is EUR 2.780
-0.060 (-2.11%)
Apr 29, 2026, 5:35 PM CET
Heidelberg Pharma AG Balance Sheet
Financials in millions EUR. Fiscal year is December - November.
Millions EUR. Fiscal year is Dec - Nov.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 | 2020 - 2016 |
| Cash & Equivalents | 14.98 | 29.42 | 43.44 | 81.33 | 6.14 | Upgrade
|
| Cash & Short-Term Investments | 14.98 | 29.42 | 43.44 | 81.33 | 6.14 | Upgrade
|
| Cash Growth | -49.10% | -32.27% | -46.59% | 1224.27% | 23.27% | Upgrade
|
| Accounts Receivable | 0.01 | 0.28 | 0.98 | 1.1 | 1.02 | Upgrade
|
| Other Receivables | 1.95 | 5.51 | 1.35 | 0.35 | 0.43 | Upgrade
|
| Receivables | 1.95 | 5.79 | 2.32 | 1.45 | 1.45 | Upgrade
|
| Inventory | 10.61 | 11.82 | 10.49 | 4.59 | 0.75 | Upgrade
|
| Prepaid Expenses | 0.79 | 0.54 | - | - | - | Upgrade
|
| Other Current Assets | - | 0 | 0.38 | 0.51 | 0.68 | Upgrade
|
| Total Current Assets | 28.33 | 47.57 | 56.63 | 87.88 | 9.01 | Upgrade
|
| Property, Plant & Equipment | 0.91 | 3.49 | 3.85 | 3.72 | 3.67 | Upgrade
|
| Goodwill | 6.11 | 6.11 | 6.11 | 6.11 | 6.11 | Upgrade
|
| Other Intangible Assets | 2.72 | 2.75 | 2.79 | 2.84 | 2.9 | Upgrade
|
| Other Long-Term Assets | 0.07 | 0.81 | 0.97 | 0.03 | 0.03 | Upgrade
|
| Total Assets | 38.14 | 60.72 | 70.35 | 100.58 | 21.73 | Upgrade
|
| Accounts Payable | 7.16 | 5.55 | 7.88 | 5.75 | 2.96 | Upgrade
|
| Accrued Expenses | 0.84 | 1.03 | 1.04 | 1.03 | 0.78 | Upgrade
|
| Short-Term Debt | - | - | 5.65 | 15.79 | 10.47 | Upgrade
|
| Current Portion of Leases | 0.1 | 0.12 | 0.11 | 0.09 | 0.09 | Upgrade
|
| Current Unearned Revenue | 0.03 | 1.2 | 4.97 | 5.02 | 0.49 | Upgrade
|
| Other Current Liabilities | 3.07 | 0.1 | 0.13 | 0.25 | 0.15 | Upgrade
|
| Total Current Liabilities | 11.21 | 8 | 19.78 | 27.93 | 14.93 | Upgrade
|
| Long-Term Leases | 0.01 | 0.05 | 0.07 | 0.1 | 0.08 | Upgrade
|
| Long-Term Unearned Revenue | 36.78 | 21.81 | 1.17 | 5.9 | 0.02 | Upgrade
|
| Other Long-Term Liabilities | 1.05 | -0 | - | - | - | Upgrade
|
| Total Liabilities | 49.05 | 29.85 | 21.01 | 33.94 | 15.03 | Upgrade
|
| Common Stock | 46.78 | 46.6 | 46.6 | 46.58 | 34.18 | Upgrade
|
| Additional Paid-In Capital | 304.99 | 304.78 | 304.78 | 304.74 | 238.05 | Upgrade
|
| Retained Earnings | -373.4 | -331.12 | -311.74 | -291.39 | -271.69 | Upgrade
|
| Comprehensive Income & Other | 10.72 | 10.6 | 9.7 | 6.71 | 6.16 | Upgrade
|
| Shareholders' Equity | -10.92 | 30.87 | 49.34 | 66.64 | 6.7 | Upgrade
|
| Total Liabilities & Equity | 38.14 | 60.72 | 70.35 | 100.58 | 21.73 | Upgrade
|
| Total Debt | 0.11 | 0.16 | 5.83 | 15.98 | 10.63 | Upgrade
|
| Net Cash (Debt) | 14.86 | 29.26 | 37.61 | 65.35 | -4.49 | Upgrade
|
| Net Cash Growth | -49.20% | -22.20% | -42.45% | - | - | Upgrade
|
| Net Cash Per Share | 0.32 | 0.63 | 0.81 | 1.76 | -0.14 | Upgrade
|
| Filing Date Shares Outstanding | 46.78 | 46.6 | 46.6 | 46.58 | 34.18 | Upgrade
|
| Total Common Shares Outstanding | 46.78 | 46.6 | 46.6 | 46.58 | 34.18 | Upgrade
|
| Working Capital | 17.12 | 39.57 | 36.86 | 59.95 | -5.92 | Upgrade
|
| Book Value Per Share | -0.23 | 0.66 | 1.06 | 1.43 | 0.20 | Upgrade
|
| Tangible Book Value | -19.75 | 22.01 | 40.44 | 57.7 | -2.31 | Upgrade
|
| Tangible Book Value Per Share | -0.42 | 0.47 | 0.87 | 1.24 | -0.07 | Upgrade
|
| Buildings | 6.44 | 8.37 | 8.1 | - | - | Upgrade
|
| Machinery | 2.42 | 2.33 | 2.23 | 9.5 | 8.91 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.